REstream Block (Upcoming)
Panel Discussion: iRAE Sessions and Studies
Panelists Dr. David Liew, Dr. Laura Cappelli, Dr. Cassandra Calabrese and Dr. Karmela Kim Chan discuss iRAE sessions and studies presented at the 2020 ACR annual meeting.
How FAST can you go? Dr. Michael Pillinger
Dr. Pillinger weighs in with his view of the FAST trial (abstract L08) presented at ACR 2020.
Cardiovascular Safety for Feboxustat with Dr. Nicola Dalbeth
Auckland's Dr. Dalbeth examines the cardiovascular safety in the FAST trial of feboxustat (abstract L08) presented at the ACR 2020.
The axSpa diagnosis, imaging and treatments: Dr. Lianne Gensler
Dr. Lianne Gensler reviews several SpA abstracts and a session on MRI presented at the 2020 ACR annual meeting. Abstracts reviews: abstract #1883, #2014, #L11 and #2022.
Adverse Events in Low-Dose Methotexate: Dr. Eric Dein
Dr. Eric Dein reviews abstract #2001 presented at the 2020 ACR annual meeting.
Pregnancy Outcomes in Lupus and SpA: Dr. Kathryn Dao
Dr. Dao reviews abstracts #1770, #1771 and #1762 presented at the 2020 ACR annual meeting.
Dr. Tom Appleton and Dr. Peter Nash Highlight OA and PsA Studies
Dr. Janet Pope interviews Dr. Tom Appleton and Dr. Peter Nash about several osteoarthritis and psoriatic arthritis studies presented at the 2020 ACR annual meeting.
sheila RHEUMarampa
3 years 10 months ago
TAK & GCA differ in vessel involvement when it comes to the 👁👁
> TAK- large vessel lesions
> GCA- small vessel vasculitis
@RheumNow #ACR20 https://t.co/sa4VEvCKOt
Dr. Antoni Chan synovialjoints
3 years 10 months ago
I would usually be on a Transatlantic flight at this point post-ACR. Going #virtual is great as I never left. What did you miss most about a face to face conference? @RheumNow #ACR20
k dao KDAO2011
3 years 10 months ago
Dr. Cush and Dr. Kavanaugh recaps the #ACR20 meeting during #RheumatologyRoundUp highlighting important studies that were presented during the mtg and how they might impact practices. Log into https://t.co/3hCmtuN7kj to view this and all our videos/news stories. @RheumNow https://t.co/HgiA1QrdIX
sheila RHEUMarampa
3 years 10 months ago
IgG4-RD tx: GCs are mainstay tx starting at 30-40mg/d tapered gradually but 30% of pts will have recurrences
Potential therapeutic targets to ⬇GC toxicity
✏B cell/plasmablasts (promising)
✏T cells (anecdotal)
@RheumNow #ACR20 https://t.co/X2NI3vFUgl
Systemic sclerosis (SSc) is a chronic fibrosing disease currently with no available cure. Just as pharmacologic treatment is important to control the disease or delay its progression, non-pharmacologic interventions are also essential in the management of patients.
Mrinalini Dey DrMiniDey
3 years 10 months ago
Reflecting on my first @ACRheum Congress- it wasn’t how I expected my first ACR to be. But #ACR20 was brilliant given the circumstances!
Easily one of the best virtual events I’ve attended- smooth platform, huge variety of sessions and efficient on-demand service.
@RheumNow
Janet Pope Janetbirdope
3 years 10 months ago
Spot diagnosis @RheumNow @CRASCRRheum #ACR20 hint this woman has 2 rheumatic diseases https://t.co/kEu9COJY3B
Poster Hall